- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 211/04 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
Patent holdings for IPC class C07D 211/04
Total number of patents in this class: 51
10-year publication summary
|
1
|
3
|
0
|
2
|
5
|
6
|
8
|
6
|
2
|
2
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Landos Biopharma, Inc. | 37 |
4 |
| Boehringer Ingelheim International GmbH | 4650 |
3 |
| The Regents of the University of California | 19918 |
2 |
| Berkeley Lights, Inc. | 112 |
2 |
| Sumitomo Bakelite Co., Ltd. | 1495 |
2 |
| Prilenia Neurotherapeutics Ltd. | 88 |
2 |
| Neophore Limited | 17 |
2 |
| Shenzhen Shenxin Biotechnology Co., Ltd. | 23 |
2 |
| Trawsfynydd Therapeutics, Inc. | 4 |
2 |
| Merck Sharp & Dohme Corp. | 2194 |
1 |
| Boehringer Ingelheim Pharma GmbH & Co. Kg | 570 |
1 |
| Merck Patent GmbH | 5831 |
1 |
| Amgen Inc. | 4074 |
1 |
| Merck Sharp & Dohme Limited | 49 |
1 |
| FUJIFILM Corporation | 29367 |
1 |
| Takeda Pharmaceutical Company Limited | 2713 |
1 |
| Dana-Farber Cancer Institute, Inc. | 2571 |
1 |
| Edward VIA College of Osteopathic Medicine | 18 |
1 |
| Eli Lilly and Company | 3842 |
1 |
| Eolas Therapeutics, Inc. | 13 |
1 |
| Other owners | 19 |